Replies to post #114712 on Biotech Values

[DewDiligence]

Have you ever seen a SINGLE ARM trial stopped for efficacy applying for regulatory approval?

I presume your question is rhetorical. Why on Earth would there be any impetus—ethical or otherwise—to stop a single-arm trial early for superior efficacy?